Your browser doesn't support javascript.
loading
Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens.
Morrison, Huntly M; Craft, Julia; Rivera-Lugo, Rafael; Johnson, Jeffery R; Golovkine, Guillaume R; Bell, Samantha L; Dodd, Claire E; Van Dis, Erik; Beatty, Wandy L; Margolis, Shally R; Repasy, Teresa; Shaker, Isaac; Lee, Angus Y; Vance, Russell E; Stanley, Sarah A; Watson, Robert O; Krogan, Nevan J; Portnoy, Daniel A; Penn, Bennett H; Cox, Jeffery S.
Afiliação
  • Morrison HM; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Craft J; Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis, Davis, California, United States of America.
  • Rivera-Lugo R; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Johnson JR; Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Quantitative Biosciences Institute (QBI), University of California, San Francisco; Gladstone Institutes, San Francisco, California, United States of America.
  • Golovkine GR; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Bell SL; Department of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, Texas, United States of America.
  • Dodd CE; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Van Dis E; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Beatty WL; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
  • Margolis SR; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Repasy T; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Shaker I; Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis, Davis, California, United States of America.
  • Lee AY; Cancer Research Laboratory, University of California, Berkeley, Berkeley, California, United States of America.
  • Vance RE; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Stanley SA; Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, California, United States of America.
  • Watson RO; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
  • Krogan NJ; School of Public Health, Division of Infectious Diseases and Vaccinology, University of California, Berkeley, Berkeley, California, United States of America.
  • Portnoy DA; Department of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, Texas, United States of America.
  • Penn BH; Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Quantitative Biosciences Institute (QBI), University of California, San Francisco; Gladstone Institutes, San Francisco, California, United States of America.
  • Cox JS; Department of Molecular and Cell Biology, Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, California, United States of America.
PLoS Pathog ; 19(6): e1011088, 2023 06.
Article em En | MEDLINE | ID: mdl-37352334

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos